Actively Recruiting
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Led by Stanford University · Updated on 2026-02-10
2000
Participants Needed
1
Research Sites
1565 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.
CONDITIONS
Official Title
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older; no subjects below 20 years for samples collected under the NIH grant
- Prior diagnosis of cancer or suspected of having cancer
- Karnofsky performance status greater than 70
- Standard pretreatment evaluation completed
- Signed Stanford University Human Subjects Committee consent form
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stanford University School of Medicine
Stanford, California, United States, 94305
Actively Recruiting
Research Team
G
gitrialeligibility@stanford.edu gitrialeligibility@stanford.edu
CONTACT
G
gitrialeligibility@stanford.edu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here